Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 205

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 205
---
 of APx’s obligations to repay the indebtedness even if APx makes all principal and interest payments when due if APx breaches certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; •APx’s immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; •the Company’s inability to obtain necessary additional financing if APx’s debt contains covenants restricting the Company’s ability to obtain such financing while the debt is outstanding; •the Company’s inability to pay dividends on the Company Shares; •using a substantial portion of APx’s cash flow to pay principal and interest on APx’s debt, which will reduce the funds available for dividends on APx’s ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; •limitations on the Company’s flexibility in planning for and reacting to changes in its business and in the industry in which it operates; 84 •increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and •limitations on the Company’s ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of the Company’s strategy and other purposes and other disadvantages compared to the Company’s competitors who have less debt. APx does not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for APx to complete the Business Combination with which a substantial majority of its shareholders do not agree. The Existing Governing Documents do not provide a specified maximum redemption threshold. As a result, APx may be able to complete the Business Combination even though a substantial majority of the Public Shareholders do not agree with the Business Combination and have redeemed their Public Shares. APx and the Company will incur significant transaction and transition costs in connection with the Business Combination. APx and the Company expect to incur significant, non -recurringcosts in connection with consummating the Business Combination. Most of these costs are payable regardless of whether the Business Combination is completed. Transaction expenses as a result of the Business Combination are currently estimated at approximately $9.66 million in the aggregate, which is comprised of fees associated with legal, audit, printing and mailing of the proxy statement/prospectus, investor relations, insurance, and other operating costs related to the Business Combination. If APx does not consummate the Business Combination, it will be required to pay its own fees and expenses, and APx likely will not